NO20011217D0 - Doseringsform omfattende væskeformulering - Google Patents

Doseringsform omfattende væskeformulering

Info

Publication number: NO20011217D0
Authority: NO; Norway
Prior art keywords: dosage form; liquid formulation; emulsifies; self; disclosed
Prior art date: 1998-09-09

Application number

NO20011217A

Other languages

English (en)

Other versions

NO20011217L (no

Inventor

Liang C Dong

Patrick S-L Wong

Steven D Espinal

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-09

Filing date

2001-03-09

Publication date

2001-03-09

2001-03-09 Application filed by Alza Corp filed Critical Alza Corp

2001-03-09 Publication of NO20011217D0 publication Critical patent/NO20011217D0/no

2001-05-08 Publication of NO20011217L publication Critical patent/NO20011217L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20011217A 1998-09-09 2001-03-09 Doseringsform omfattende v¶skeformulering NO20011217L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9961998P	1998-09-09	1998-09-09
PCT/US1999/020332 WO2000013663A1 (en)	1998-09-09	1999-09-03	Dosage form comprising liquid formulation

Publications (2)

Publication Number	Publication Date
NO20011217D0 true NO20011217D0 (no)	2001-03-09
NO20011217L NO20011217L (no)	2001-05-08

Family

ID=22275865

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011217A NO20011217L (no)	1998-09-09	2001-03-09	Doseringsform omfattende v¶skeformulering

Country Status (19)

Country	Link
EP (1)	EP1112060B1 (no)
JP (1)	JP2002524407A (no)
KR (1)	KR100620292B1 (no)
CN (1)	CN1227003C (no)
AT (1)	ATE311858T1 (no)
AU (1)	AU751086B2 (no)
CA (1)	CA2341297C (no)
CY (1)	CY1105465T1 (no)
DE (1)	DE69928815T2 (no)
DK (1)	DK1112060T3 (no)
ES (1)	ES2251840T3 (no)
HK (1)	HK1038508B (no)
HU (1)	HU226669B1 (no)
IL (2)	IL141914A0 (no)
NO (1)	NO20011217L (no)
NZ (1)	NZ510020A (no)
RU (1)	RU2227021C2 (no)
WO (1)	WO2000013663A1 (no)
ZA (1)	ZA200101994B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL164163A0 (en) *	2002-04-09	2005-12-18	Pharmacia Corp	Process for preparing a finely self-emulsifiable pharmaceutical composition
UY28056A1 (es) *	2002-10-31	2003-12-31	Alza Corp	Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2007083323A2 (en) *	2006-01-23	2007-07-26	Panacea Biotec Limited.	Modified release oral dosage form comprising desmopressin
DE602007009377D1 (de)	2006-05-30	2010-11-04	Intarcia Therapeutics Inc	Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en)	2006-08-09	2013-05-22	Intarcia Therapeutics, Inc	Osmotic delivery systems and piston assemblies
CN104000779A (zh)	2007-04-23	2014-08-27	精达制药公司	促胰岛素释放肽的混悬制剂及其应用
CA2726861C (en)	2008-02-13	2014-05-27	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
NO2462246T3 (no)	2009-09-28	2018-02-03
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103933017A (zh) *	2014-03-26	2014-07-23	邵娜	一种黄体酮缓释胶囊
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
TWI754643B (zh)	2016-05-16	2022-02-11	美商因塔希亞治療公司	升糖素受體選擇性多肽和彼之使用方法
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
WO2018129058A1 (en)	2017-01-03	2018-07-12	Intarcia Therapeutics, Inc.	Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
CN115490316B (zh) *	2022-01-24	2023-09-12	成都理工大学	一种可再利用的地下水营养物质缓释胶囊体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH580961A5 (en) *	1972-01-13	1976-10-29	Alza Corp	Dispenser - functioning by osmotic pressure using active agents in solid or semi solid form
US3845770A (en) *	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US4327725A (en) *	1980-11-25	1982-05-04	Alza Corporation	Osmotic device with hydrogel driving member
AU591171B2 (en) *	1983-11-02	1989-11-30	Alza Corporation	Dispenser for delivering thermo-responsive composition
GB2155889B (en) *	1984-03-21	1988-03-02	Alza Corp	Dispenser-capsule
US4842867A (en) *	1986-05-09	1989-06-27	Alza Corporation	Pulsed drug delivery of doxylamine
US5324280A (en) *	1990-04-02	1994-06-28	Alza Corporation	Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
EP0716595B1 (en) *	1993-08-31	1998-11-25	Alza Corporation	Dispenser containing hydrophobic agent
ZA953078B (en) *	1994-04-28	1996-01-05	Alza Corp	Effective therapy for epilepsies
WO1995034285A1 (en) *	1994-06-13	1995-12-21	Alza Corporation	Dosage form for administering drug in liquid formulation
US5633011A (en) *	1994-08-04	1997-05-27	Alza Corporation	Progesterone replacement therapy
US5904935A (en) *	1995-06-07	1999-05-18	Alza Corporation	Peptide/protein suspending formulations

1999
- 1999-09-03 WO PCT/US1999/020332 patent/WO2000013663A1/en not_active Ceased
- 1999-09-03 CA CA002341297A patent/CA2341297C/en not_active Expired - Fee Related
- 1999-09-03 NZ NZ510020A patent/NZ510020A/xx unknown
- 1999-09-03 IL IL14191499A patent/IL141914A0/xx active IP Right Grant
- 1999-09-03 RU RU2001107030/15A patent/RU2227021C2/ru not_active IP Right Cessation
- 1999-09-03 KR KR1020017003055A patent/KR100620292B1/ko not_active Expired - Fee Related
- 1999-09-03 HK HK02100030.0A patent/HK1038508B/en not_active IP Right Cessation
- 1999-09-03 DK DK99944089T patent/DK1112060T3/da active
- 1999-09-03 ZA ZA200101994A patent/ZA200101994B/en unknown
- 1999-09-03 ES ES99944089T patent/ES2251840T3/es not_active Expired - Lifetime
- 1999-09-03 AU AU57051/99A patent/AU751086B2/en not_active Ceased
- 1999-09-03 EP EP99944089A patent/EP1112060B1/en not_active Expired - Lifetime
- 1999-09-03 HU HU0104034A patent/HU226669B1/hu not_active IP Right Cessation
- 1999-09-03 DE DE69928815T patent/DE69928815T2/de not_active Expired - Lifetime
- 1999-09-03 JP JP2000568472A patent/JP2002524407A/ja active Pending
- 1999-09-03 CN CNB998107549A patent/CN1227003C/zh not_active Expired - Fee Related
- 1999-09-03 AT AT99944089T patent/ATE311858T1/de active
2001
- 2001-03-08 IL IL141914A patent/IL141914A/en not_active IP Right Cessation
- 2001-03-09 NO NO20011217A patent/NO20011217L/no not_active Application Discontinuation
2006
- 2006-03-03 CY CY20061100301T patent/CY1105465T1/el unknown

Also Published As

Publication number	Publication date
ZA200101994B (en)	2002-03-11
JP2002524407A (ja)	2002-08-06
NO20011217L (no)	2001-05-08
KR100620292B1 (ko)	2006-09-13
DK1112060T3 (da)	2006-04-18
WO2000013663A1 (en)	2000-03-16
RU2227021C2 (ru)	2004-04-20
NZ510020A (en)	2003-06-30
HUP0104034A3 (en)	2002-12-28
CA2341297A1 (en)	2000-03-16
HUP0104034A2 (hu)	2002-04-29
CN1316897A (zh)	2001-10-10
ES2251840T3 (es)	2006-05-01
DE69928815D1 (de)	2006-01-12
EP1112060B1 (en)	2005-12-07
AU5705199A (en)	2000-03-27
EP1112060A1 (en)	2001-07-04
ATE311858T1 (de)	2005-12-15
CA2341297C (en)	2009-02-24
AU751086B2 (en)	2002-08-08
CN1227003C (zh)	2005-11-16
IL141914A0 (en)	2002-03-10
CY1105465T1 (el)	2010-04-28
DE69928815T2 (de)	2006-06-29
KR20010086394A (ko)	2001-09-10
HU226669B1 (en)	2009-06-29
HK1038508A1 (en)	2002-03-22
IL141914A (en)	2008-06-05
HK1038508B (en)	2006-06-30

Publication	Publication Date	Title
NO20011217D0 (no)	2001-03-09	Doseringsform omfattende væskeformulering
ATE312602T1 (de)	2005-12-15	Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
NO20022970L (no)	2002-06-20	Hydrogel-drevet medikamentdoseringsform
NO20022998D0 (no)	2002-06-21	Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
DE69525148D1 (de)	2002-03-14	Pharmazeutische formulierung
DE60019334D1 (de)	2005-05-12	Antivirale arznei
DE69928085D1 (de)	2005-12-08	Dosierungsform mit verlängerter wirkstoffabgabe
NO20030627L (no)	2003-04-08	Hydrogel-drevet medikament doseringsform
DK1208864T4 (da)	2012-08-06	Forbedringer til lægemiddelafgivelsesindretninger
EE04002B1 (et)	2003-04-15	Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
DE69938299D1 (de)	2008-04-17	Lokale abgabe von arzneimitteln
EE04003B1 (et)	2003-04-15	Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
DE69928777D1 (de)	2006-01-12	Dosierspender
DE69923076D1 (de)	2005-02-10	Transthorakale arzneimittelabgabevorrichtung
ID22565A (id)	1999-11-11	Penggunaan nanodispersi dalam formulasi akhir obat
FI941197A7 (fi)	1994-09-16	Lääkkeenannostuslaite
BR9607851B1 (pt)	2009-01-13	combinaÇço e formulaÇço farmacÊutica.
PT768867E (pt)	2003-01-31	Forma de dosagem para a administracao de droga em formulacao liquida
ATE429224T1 (de)	2009-05-15	Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
ATE383868T1 (de)	2008-02-15	Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
EE05415B1 (et)	2011-06-15	Ravimi manustamise vahend, eriti androgeenide manustamiseks
DE60102590D1 (de)	2004-05-06	Darreichungsformen zur behandlung von oralen mykosen
ATE304844T1 (de)	2005-10-15	Entzündungshemmende pharmazeutische formulierungen
AR242907A1 (es)	1993-06-30	Dispositivo de doble punta para dosificar y suministrar medicamentos.

Legal Events

Date	Code	Title	Description
2010-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application